Tuesday, November 24, 2009, 7:27pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Elan Corp. plc (ELN)

At 5:01AM SGT: 6.35 USD   0.00 (0.00%)  
 MORE ON ELN 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 ELAN CP PLC ADR (NYSE:ELN) Delayed quote dataEdit
Last Trade:6.35 USD
Trade Time:5:01AM SGT
Change: 0.00 (0.00%)
Prev Close:6.35
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:8.26
Day's Range:N/A - N/A
52wk Range:4.61 - 9.13
Volume:0
Avg Vol (3m):4,460,780
Market Cap:3.12B
P/E (ttm):59.91
EPS (ttm):0.11
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add ELN to Portfolio   Download Data

 HEADLINES 
•UPDATE - HealthCor slams Biogen CEO for outsize pay package
at Reuters (Sat, Nov 21)
•Thursday Options Recap
at Seeking Alpha (Fri, Nov 13)
•When Rival Drug Makers Compare Notes On Safety Problems
at The Wall Street Journal Online (Thu, Nov 12)
•Cramer's Lightning Round - The Only Water Stock Worth Buying (11/10/09)
at Seeking Alpha (Wed, Nov 11)
•Lightning Round: Priceline.com, Citigroup, Transocean and More
at CNBC (Wed, Nov 11)
•Elan to Present at Lazard Capital Markets 6th Annual Healthcare Conference
Business Wire (Wed, Nov 11)
•Successful Pharmaceutical Company Mergers: Abbott Labs Is Leader
Wall Street Transcript (Tue, Nov 10)
•A Bear in the Bullpen: 3 Power Ratings Stocks Ready to Drop
TradingMarkets.com (Mon, Nov 9)
•Elan, Biogen change Tysabri label due to PML risk
at Reuters (Sat, Nov 7)
•Nice Quarter, Teva. What Will You Buy Next?
at Motley Fool (Wed, Nov 4)
•UPDATE - J&J slashing workforce, cites cost of drug research
at Reuters (Wed, Nov 4)
•Johnson & Johnson to cut up to 8,200 jobs
at MarketWatch (Wed, Nov 4)
•Healthcare Earnings Are Coming Into Focus
at Investopedia (Sat, Oct 31)
More Headlines for ELN...
 ANALYST 
EPS Est (next year) (Dec-09) :-0.47
EPS Est (in 2 years) (Dec-10) :-0.19
Avg Rec (current)*:2.9
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Elan Corporation, plc operates as a neuroscience-based biotechnology company primarily in Ireland and the United States. It operates in two segments, Biopharmaceuticals and Elan Drug Technologies (EDT).

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices